Home/Filings/4/0001062993-23-011932
4//SEC Filing

Shantharam Harish 4

Accession 0001062993-23-011932

CIK 0001042074other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 5:13 PM ET

Size

5.4 KB

Accession

0001062993-23-011932

Insider Transaction Report

Form 4
Period: 2023-05-22
Shantharam Harish
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-05-22+360,000360,000 total
    Exercise: $8.76Exp: 2033-05-21Common Stock (360,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on May 22, 2024 and vests as to 1/48 of the underlying shares monthly thereafter.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001976391

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:13 PM ET
Size
5.4 KB